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Yves Henrotin1, Alain Labasse2, Thierry Franck3, Alain Bosseloir4, Thierry Bury5 and Michelle Deberg2*Abstract
To determine the influence of marathon on the serum levels of two markers of cartilage degradation, Coll2-1 and
its nitrated form, Coll2-1NO2, and of a marker of neutrophils activation, the myeloperoxidase (MPO).
Coll2-1, Coll2-1NO2, total and active MPO were measured in 98 marathon runners without joint pain and with an
average age of 47 years. Sera were taken at rest right before the departure and within 30 min after the marathon.
The subjects were submitted to a questionnaire concerning their physical activity and their life style.
The levels of Coll2-1, Coll2-1NO2 and active MPO were not affected by age, body mass index, sex or performance.
The levels of total MPO were higher in female than in male (p < 0.05), but were not affected by the other
parameters. After the marathon, Coll2-1 and Coll2-1NO2 concentrations were slightly but systematically decreased.
The total and active MPO concentrations were increased by 2 to 3-fold in comparison to the pre-marathon values
(p < 0.001 for total and active MPO). The active MPO/total MPO ratio was significantly enhanced after the marathon
(p < 0.001). The variation of total MPO during the marathon was negatively correlated with the training time per
week (r = −0.34; p = 0.009).
The serum levels of Coll2-1 and Coll2-1NO2 were slightly decreased by marathon, indicating that intensive running
could reduce cartilage catabolism. Furthermore, Coll2-1NO2 was not correlated with the total and active MPO
indicating that Coll2-1 nitration did not result of a systemic oxidative phenomenon but reflects local changes.
Keywords: Cartilage, Endurance exercise, Type II collagen, BiomarkersIntroduction
Intensive exercises such as marathon running, induce
a systemic inflammatory syndrome characterized by
neutrophilia and increased plasmatic concentration of
myeloperoxidase (MPO), pro-inflammatory cytokines
such as interleukin (IL)-1, -6, -8, tumor necrosis fac-
tor (TNF) alpha and granulocyte-colony stimulating
factor (G-CSF) (Suzuki et al. 2003). Furthermore, they
induce neutrophils and cytokines accumulation in da-
maged muscles (Fielding et al. 1993; Hellsten et al. 1997;
Suzuki et al. 2000; Nieman 2000) and subsequently the re-
lease of myocellular proteins such as creatine kinase (CK)
and myoglobulin into the circulation (Bruunsgaard et al.
1997; Suzuki et al. 1999; Suzuki et al. 2000). It has further* Correspondence: Michelle.Deberg@artialis.com
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in any medium, provided the original work is pbeen hypothesized that marathon could increase cartilage
matrix turnover, a phenomenon suspected to be related to
systemic inflammatory syndrome. This hypothesis is based
on the observation that the increased serum level of cartil-
age oligomeric matrix protein (COMP) during marathon
is associated with the early release of soluble IL-6 receptor
(sIL-6R), TNFα, IL-1 receptor antagonist (IL-1Ra) and
soluble TNF receptors II (sTNFRII) (Camus et al. 1997;
Northoff and Berg 1991; Nehlsen-Cannarella et al. 1997;
Ostrowski et al. 1998; Neidhart et al. 2000). However,
there is no evidence whether the serum level of COMP re-
flects pathological changes occurring in cartilage. Indeed,
COMP is present in cartilage but also in other tissues such
as tendons and synovial membrane (Neidhart et al. 1997;
Di Cesare et al. 1997; Hummel et al. 1998) which might
also be activated during or after physical exercises. In
addition, COMP is released into the synovial fluid and
blood in its intact or fragmented forms. This matters an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Anthropometric data, training history and
performance of marathon runners (n = 98)
Variables Mean (SD) Range
Age (year) 45.84 (7.77) 27–60
Sex ratio (Male/Female; %) 79.6/20.4 –
BMI (kg/m2) 22.9 (2.00) 18.37–27.76
Weekly training (min) 371.05 (207.67) 120.00–900.00
Performance [race time (min)] 195.56 (33.35) 94.00–304.00
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breakdown. In general, the immunoassay used in these
studies is not able to differentiate the various fragmented
forms of COMP. Consequently, it cannot be concluded if
the increased serum levels represent either cartilage ca-
tabolism or just an elevated metabolic rate. On the other
hand, Sweet et al. (Sweet et al. 1992) have shown that
marathon race did not increase the serum levels of other
markers such as keratan sulfate from the departure to 48
hours after the completion of the race. Therefore, the ef-
fects of long distance running on cartilage metabolism re-
main questionable. Moreover, several studies investigating
cartilage by magnetic resonance imaging (MRI) have
shown that competitive or leisure long-distance runners
experienced no major short-term or long-term knee cartil-
age damages, considering that there was no evidence of
pre-existing damage (Lazzarini et al. 1997; Colbert et al.
2000; Lohman et al. 2001; Krampla et al. 2008; Schueller-
Weidekamm et al. 2006).
To investigate the effects of long-distance running on
type II collagen metabolism, we have measured Coll2-1
and Coll2-1NO2 in the serum of marathon runners be-
fore and immediately after the race. Coll2-1 is a nine
amino acid sequence (108HRGYPGLDG116 ) located in
the helical part of type II collagen molecule, a specific
and major protein of articular cartilage. Coll2-1 is a
well-recognized marker of type II collagen catabolism
(Deberg et al. 2005a; Huebner et al. 2010). Furthermore,
this peptide contains a tyrosine which is sensitive to ni-
tration. The nitrated form of Coll2-1 is called Coll2-
1NO2 [
108HRGY(NO2)PGLDG
116] and represents the
oxidation related to the cartilage degradation. Even if we
cannot exclude that nitration occurs outside the joint,
Coll2-1NO2 illustrates the oxidative-related cartilage
matrix degradation. Recently, we have developed specific
immunoassays (ELISA) to measure in serum Coll2-1 in
its native or nitrated forms. The mean serum levels of
these epitopes in adults aged 20–65 years did not vary
with age and do not show diurnal variation. Coll2-1 and
Coll 2-1NO2 were significantly elevated in osteoarthritic
patients compared to age-matched controls (Henrotin
et al. 2004). Additionally, the ratio Coll2-1NO2/Coll2-1
was shown to differentiate rheumatoid arthritis (RA)
from osteoarthritis (OA) with a 1.6 fold higher ratio in
RA than in OA (Deberg et al. 2005a). Finally, high levels
of Coll2-1 and Coll2-1NO2 in the urine of OA patients
have been shown to predict the progression of radio-
graphic joint space narrowing over one year (Deberg
et al. 2005b).
In this article, we report Coll2-1 and Coll2-1NO2
serum levels and the levels of other biochemical markers
(MPO and C-reactive protein (CRP)) to further elucidate
the effects of marathon running on cartilage degrad-
ation. MPO is a hemoprotein expressed in the primarygranules of neutrophil polymorphonuclear leukocytes
which uses hydrogen peroxide (H2O2) and Cl
- to form a
powerful oxidant, hypochlorous acid (HOCl) (Deby-
Dupont et al. 1999). MPO also catalyzes tyrosine nitra-
tion in proteins from nitrite and H2O2 (Sampson et al.
1998). Therefore, we hypothesize that MPO could be re-
sponsible for Coll2-1 peptide nitration and that Coll2-1
nitration could occur outside the cartilage. Indeed, MPO
is not expressed in cartilage. To verify this hypothesis,
we have measured Coll2-1NO2 in the serum of mara-
thon runners just after the race. At this time, it is known
that a high concentration of MPO is released in the
blood and a systemic oxidative stress occurs (Camus
et al. 1997; Melanson et al. 2006). The absence of Coll2-
1NO2 increase after the marathon would suggest that
Coll2-1 nitration is not a systemic phenomenon. This
study was designed: (1) to investigate the effects of long
distance running on type II collagen catabolism; (2) to
study the impact of a systemic oxidative stress on Coll2-1
peptide nitration; (3) to determine the change of the active
fraction of MPO during marathon.
Methods
Population
The study was conducted in 98 participants (78 men
and 20 women, mean age (SD): 45.84 (7.77) years; range:
27.00–60.00) at a 42.195 Km marathon. Their demo-
graphic characteristics are summarized in Table 1. All
were non-smokers, in good health with no history of fe-
brile disease in the month before the race. None were
taking any medication within two weeks before the race.
None were subjected to bone radiological and/or scintig-
raphy and none had any evidence of renal or liver fail-
ure, arthritis or other inflammatory diseases. None was
currently taking any medication known to modify arth-
ritic disease or influence joint metabolism.
The runners completed the race in an average of
198.81 ± 30.94 minutes (mean ± SD; ranged from 148 to
304 min). All the runners were deemed in medically
stable condition at the end of the marathon. The study
was approved by the local ethics committee. Subjects
were informed of the experimental procedures and pos-
sible risks, and signed a letter of informed consent be-
fore participating.
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The blood samples were collected at rest before and
within 30 min after the race. Peripheral blood samples
were collected in Vacutainers by antecubital venipun-
cture with the subject in a sitting position. Samples were
allowed to clot 30 min at room temperature before being
centrifuged at 1000 g for 10 min. The sera were ali-
quoted and stored at −80°C until their analysis. All sam-
ples were thawed only once.
Immunoassays for Coll2-1 and Coll2-1NO2
Coll2-1 and Coll2-1NO2 concentrations were measured
by two competitive and specific immunoassays (ELISA)
(Deberg et al. 2005a). The Coll2-1 immunoassay mea-
sured the amino acid sequence 108HRGYPGLDG116 in
its linear form whereas the Coll2-1NO2 immunoassay
quantified the nitrated amino acids sequence. The limits
of detection were 17 nM for Coll2-1 immunoassay and
25 pM for Coll2-1NO2 immunoassay. The intra- and
inter-assays coefficients of variation (CV) were lower than
10% and the dilution curves were parallel to the standard
curve for both assays. The analytical recoveries were in
mean 104.7% and 121.9% for Coll2-1 and Coll2-1NO2 as-
says respectively.
Briefly, microplates were coated with 200 μl of strep-
tavidine 0.5 μg/ml during 48 hours. After washing
(washing buffer: Tris 25 mM, NaCl 50 mM, Tween 20
0,2% (v/v) pH 7.3), microtiter plates (Maxisorp, Nunc,
Denmark) were blocked with 400 μl/well of blocking
buffer (KH2PO4 1.5 mM, Na2HPO4 8 mM, KCl 2 mM,
NaCl 138 mM, BSA 0.5% (v/v) pH 7.2) overnight at 4°C.
Coll2-1 and Coll2-1NO2 peptides were conjugated to
biotin according to the method described by Rosenquist
et al. (Rosenquist et al. 1998). One hundred μl of the
biotinylated peptides (Coll2-1 at 2.5 ng/ml or Coll2-
1NO2 at 1.25 ng/ml) were added to each well of the
streptavidine-coated plates and incubated for two hours
at room temperature. After washing, 50 μl of calibrators
(synthetic peptide) or unknown samples, diluted in incu-
bation buffer (10 mM phosphate buffer saline (PBS), 138
mM NaCl, 7% (w/v) BSA, 0.1% (v/v) Tween 20 pH 7.0
for the Coll2-1 immunoassay and in 50 mM Tris, 138
mM NaCl, 7% (w/v) BSA, 0.1% (v/v) Tween 20 pH 8.0
for the Coll2-1NO2 immunoassay), were added to the
wells, followed by either 100 μl of D3 antibody (for
Coll2-1, diluted 1/40,000) or 100 μl of D37 antibody (for
Coll2-1NO2, diluted 1/500,000) and incubated one hour
at room temperature. The dilutions of the antisera and
of the secondary antibody were done in dilution buffer
(10 mM PBS, 138 mM NaCl, 0.2% (w/v) BSA, 0.1% (v/v)
Tween 20 pH 7.0 for the Coll2-1 immunoassay and in
50 mM Tris, 138 mM NaCl, 0.2% (v/v) BSA, 0.1% (v/v)
Tween 20 pH 8.0 for the Coll 2-1NO2 immunoassay).
One hundred μl of peroxidase-conjugated goat antibodiesto rabbit IgG (Biosource, Belgium), diluted 1/5000 in incu-
bation buffer, were incubated one hour at room tem-
perature. Washing steps were performed between each
incubation. Finally, 100 μl of freshly prepared enzyme sub-
strate [3,3’,5,5’-Tetramethylbenzidine (TMB), Biosource,
Belgium] were added into each well. After 15 minutes, the
reaction was stopped with 100 μl of 4M H3PO4. The col-
oration was read with a microplate reader (Labsystem,
Finland) at 450 nm, corrected for absorbance at 650 nm.
Total MPO by ELISA
The total MPO concentration in sera was measured by a
solid phase two-site enzyme linked immunosorbent as-
say, as described by the manufacturer (ELIZEN MPO,
Zentech SA, Liège, Belgium), in which the capture and
the detection antibodies were two polyclonal antibodies.
The performances of the assay were: a sensitivity equal
to 0.4 ng/ml, the inter- and intra-assays CV lower than
15%, an accuracy between 89 and 104% and the dilution
curves parallel to the standard curve.
Active MPO by SIEFED (Specific immunological extraction
followed by enzymatic detection)
The measurement of active MPO was realized as de-
scribed by Franck et al. (Franck et al. 2006) and adapted
for human MPO activity measurement (Franck et al.
2009). Briefly, MPO in the biological fluid was captured
on specific immobilized antibodies. After washing to
eliminate unspecifically bound compounds or interfering
substances, the detection of MPO enzymatic activity was
performed by using H2O2 as substrate, Amplex Red as
fluorogenic electron donor and nitrite as enhancer of
the reaction. The intra- and inter-assay CV were un-
der 10 and 20%, respectively. The limit of detection was
0.40 ng/ml.
Biochemical measurements standard
Serum samples pre-and post-marathon were analyzed on
the Roche/Cobas Integra 400/700/800 system (Roche
Diagnostics) using reagents supplied by the manufacturer.
Total proteins, albumin and uric acid in sera were mea-
sured spectrophotometrically. Total creatine kinase (CK)
was determined by a kinetic method. CRP (C-reactive
protein) was measured by immunoturbimetry (Roche
Diagnostcis GmbH, Mannheim, Germany).
Statistical analysis
The Coll2-1, Coll2-1NO2, CK, uric acid, albumin, total
protein, CRP, total MPO, active MPO and active MPO/
total MPO ratio values measured before and after the
marathon race were expressed as median (range). Statis-
tical analyses were carried out with GraphPad InStat3.
Wilcoxon matched pairs test was used to compare each
biological marker values before and after the marathon
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biological markers (Coll2-1, Coll2-1NO2, total MPO, ac-
tive MPO, CRP, albumin, total protein, uric acid, creatine
kinase) and on marathon characteristics (training time
and performance), a regression analysis was performed.
The correlations between the different biological mar-
kers before and the variation during the marathon were
estimated by the non-parametric Spearman’s rank correl-
ation coefficient. Data were considered statistically signifi-
cant when P value was below 0.05 (two-tailed test).
Results
Cartilage biomarkers
The levels of Coll2-1 and Coll2-1NO2 measured right
before the race were not affected by age, BMI, sex, trai-
ning time and performance. Coll2-1 and Coll2-1NO2
concentrations were significantly decreased after the ma-
rathon, [Coll2-1 pre: 107.79 (28.77–296.94) nM; Coll2-1
post: 93.45 nM (28.89–278.87) (p < 0.001) and Coll2-
1NO2 pre: 0.26 (0.05–0.71) nM, Coll2-1NO2 post: 0.21
(0.05–0.61) (p < 0.001)] (Table 2). The reduction was ob-
served in 73.7% of the participants for Coll2-1 and in
57.9% of participants Coll2-1NO2. There was no differ-
ence between men and women values before and after
the race.
Neutrophil activation and systemic inflammation markers
The pre-marathon levels of total MPO measured right
before the race were significantly higher in female [me-
dian: 57.70 (<0.40–216.74) ng/ml] than in male [median:
38.40 (15.60–343.39) ng/ml] (p < 0.05). By contrast, the
levels of CRP were not statistically different [male 0.84
(0.00–7.00) mg/l and female 0.83 (0.00–8.00) mg/l]. The
serum levels of CRP and total MPO were not correlated
with age, BMI, performance and training time before the
marathon. After the marathon, the levels of MPO and
CRP increased in 89% and 15.4% of the participants re-
spectively [MPO pre: 42.30 (<0.40–343.49) ng/ml and
MPO post: 94.40 (13.47–465.30) ng/ml; CRP pre: 0.84Table 2 Pre- and post-marathon values of biochemical marke
Marker Pre-marathon
Total protein (mg/ml) 78.21 (67.54–90.55)
Albumin (g/l) 45.00 (40.00–53.00)
Uric Acid (mg/l) 47.00 (25.00–72.00)
Creatine kinase (U/l) 59.00 (11.00–200.00)
CRP (mg/l) 0.84 (0.00–8.00)
Total MPO (ng/ml) 42.30 (<0.40–343.39)
Active MPO (ng/ml) 4.05 (<0.40–50.68)
Active MPO/Total MPO ratio (%) 7.73 (0.00–61.49)
Coll2-1 (nM) 107.79 (28.77–296.94)
Coll2-1NO2 (nM) 0.26 (0.05–0.71)(0.00–8.00) mg/l and CRP post: 1.06 (0.00–12.00) mg/l]
(Table 2). No difference was observed between men and
women after the race.
Before the marathon, there was no difference of active
MPO between men and women [men: 4.15 (<0.40–50.68)
ng/ml and women 3.46 (<0.40–33.35) ng/ml]. No correl-
ation between pre-marathon active MPO values and BMI,
age, training time and performance was observed. After
the marathon, the active MPO was significantly in-
creased [pre-marathon values: 4.05 (<0.40–50.68) ng/ml
and post-marathon values: 11.63 (<0.40–175.23) ng/ml
(p < 0.0001)]. After the marathon, no difference between
men and women was observed [men: 11.73 (0.86–175.23)
ng/ml and women 7.83 (<0.40–28.73) ng/ml]. Finally, in
comparison with the pre-marathon values, the ratio active
MPO/total MPO was increased after the race [pre-mara-
thon: 7.73 (0.00–61.49) % vs post-marathon: 13.72 (0.07–
92.68) % (p < 0.0001)]. A positive correlation was found
between active MPO and total MPO (r = 0.67; p < 0.001).
No relationship was observed between MPO activity and
CRP, Coll2-1NO2.
Biochemical markers
Before the marathon, total protein and albumin values
were not affected by age, BMI, sex, training time and
performance at the marathon. After the marathon, total
protein and albumin concentrations significantly increased
[total protein pre-marathon: 78.21 (67.54–90.55) mg/ml;
post-marathon: 81.40 (65.16–92.30) mg/ml and albumin
pre-marathon: 45 (40.00–53.00) g/l; post-marathon: 47.00
(41.00–54.00) g/l; p < 0.001]. The elevations of total
protein and albumin levels were moderate (total pro-
tein: 3.64 ± 0.45% and albumin: 3.88 ± 0.44%) but were
present in all subjects.
Pre-marathon CK levels were more elevated in male
[median: 62.00 (22.00–200.00) U/l/] than in female
[median: 54.50 (11.00–164.00) U/l] but the difference
was not significant (p = 0.074). No correlation of pre-ma-












Figure 1 Correlation (r = −0.34, p = 0.009) between the
variation of total MPO during the marathon and the time of
weekly training.
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by an average of 3.6 fold [pre-marathon: 59.00 (11.00–
200.00) U/l; post-marathon: 212.00 (44.00–2020.00) U/l]
(Table 2). The increase of CK levels and the post-mara-
thon levels were similar in men and women.
Pre-marathon serum uric acid levels were more ele-
vated in men [48.00 (32.00–72.00) mg/l] than in women
[36.00 (25.00–67.00) mg/l] (p < 0.001). No correlation
between pre-marathon uric acid values and the BMI, the
training time and the performance was observed. After
the marathon, the uric acid concentrations were in-
creased by 1.17-fold [pre: 47.00 (25.00–72.00) mg/l; post:
55.00 (31.00–80.00) mg/l] (p < 0.001) (Table 2) and the
difference between men and women levels was still pre-
sent [men: 57.00 (35.00–77.00) mg/l and women: 44.00
(31.00–80.00) mg/l] (p = 0.01).
Correlations between biological markers, demographic
characteristics before the race and changes in serum
concentrations after the marathon
A multiple regression analysis was employed to test to
what extent the variability of changes in biological mar-
kers during the marathon could be explained by de-
mographic parameters, training time or performance.
A significant positive correlation was found for total
protein changes during marathon and BMI (r = 0.24,
p = 0.02) as well as for albumin changes and age (r = 0.21;
p = 0.05). The variation of total MPO levels during the
race, but not active MPO or active MPO/total MPO ratio,
was negatively correlated with the weekly training time
(r = −0.34, p = 0.009) (Figure 1). The changes in active
MPO levels during the marathon was negatively cor-
related with the age (r = −0.25, p = 0.03). The other bio-
markers changes were not correlated with age, BMI,
training time or performance.
None of the biomarkers levels before the race was cor-
related with changes during the marathon.
Discussion
Previous studies, that investigated acute stress on the
knee caused by marathon running, revealed controver-
sial results most likely due to their small number of par-
ticipants and the crossed distance (Neidhart et al. 2000;
Krampla et al. 2001; Wu et al. 2004; Schmitt et al. 2006;
Schueller-Weidekamm et al. 2006; Kim et al. 2007).
The main result of our study was that the serum levels
of Coll2-1 and Coll2-1NO2 slightly, but systematically
and significantly, decreased after the marathon, whereas
total protein concentrations increased. This finding indi-
cates that the changes in Coll2-1 and Coll2-1NO2 levels
do not result of a global change in connective tissue me-
tabolism, but well of a change in cartilage metabolism.
To our knowledge, this study is the first one to demon-
strate the effects of an intensive running on collagencatabolism. Previous studies have reported that the se-
rum levels of keratan sulfate, a component of aggrecan,
were unchanged in runners immediately after a mara-
thon (Sweet et al. 1992), and that the serum levels of
COMP were increased during and after the marathon
(Neidhart et al. 2000). In human, COMP is produced in
cartilage by chondrocytes and in tendons, menisci, and
synovial tissue by fibroblasts (Di Cesare et al. 1997;
Hummel et al. 1998). Therefore, the rise in COMP se-
rum concentrations during the marathon may be indica-
tive of the severe physical strain on joint structure, but
may also be associated with tendonitis, synovitis or me-
niscus injury. In contrast, Coll2-1 is specific of cartilage
tissue. Coll2-1 is a denaturation epitope located in tri-
ple helical domain of the type II collagen molecule that
is made available by unwinding of the triple helix
(Henrotin et al. 2007). Coll2-1 and Coll2-1NO2 were
found to be elevated in the serum of OA patients
(Deberg et al. 2005a) and in OA cartilage (Deberg et al.
2008). These observations revealed that Coll2-1 was a
specific marker of the cartilage degradation. Therefore,
the decrease in Coll2-1 levels in post-marathon serum
could be interpreted as a protective effect of long dis-
tance running on cartilage. This hypothesis is supported
by the works of Neidhart et al. (Neidhart et al. 2000)
that demonstrated that the serum levels of IL-1 receptor
antagonist (IL-1Ra) highly increased during the mara-
thon and remained elevated two hours after the mara-
thon completion, whereas the serum levels of IL-1β
were unchanged. IL-1Ra competes with IL-1 for the
same receptor without having intrinsic activity. By this
way, IL-1Ra limits the deleterious effect of IL-1β on car-
tilage (Caron et al. 1996). IL-1β is known to be the key
cytokine in cartilage degradation in OA. IL-1β stimulates
the production of matrix metalloproteases and reac-
tive oxygen species by chondrocytes and decreases the
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could conclude that the decrease of the serum levels of
serum Coll2-1 at the completion of the marathon, could
result of the inhibition of IL-1β activity by IL-Ra.
Another explanation could be that the decrease in the
serum level of Coll2-1 results of an increase in Coll2-1
clearance secondary to prolonged exercise as previous-
ly observed with MPO in marathon (Suzuki et al. 2003).
As previously reported, the serum levels of MPO were
highly increased after marathon indicating that long dis-
tance race induces neutrophil degranulation (Camus
et al. 1997). For the first time, we have also measured
serum active MPO using an original method called
SIEFED (‘Specific Immunological Extraction Followed by
Enzymatic Detection’) allowing the study of the enzyme
without interference of the biological sample. In this
assay, first, blood MPO was captured on specific im-
mobilized antibodies, secondly, not specifically bound
compounds or interfering substances were eliminated by
washings and, third, MPO enzymatic activity was re-
vealed fluorimetrically. With this method, we have found
that not only total MPO, but also active MPO were in-
creased suggesting that a systemic oxidative stress and a
production of hypochloric acid and derivatives oxidants
could occur after a marathon. Interestingly, MPO and
active MPO before or after the marathon were not cor-
related with Coll2-1NO2. This finding supports the con-
cept that Coll2-1 nitration does not result of systematic
oxidative stress, but rather reflects oxidative stress oc-
curring in the joints. The variation of total MPO during
the marathon, but not active MPO or active MPO/total
MPO ratio, was negatively correlated with the weekly
training time. This result indicates that the training pre-
vents from neutrophils degranulation during marathon.
This finding also suggests that the blood concentration
of total MPO could be a useful marker for the follow-up
of training.
Another important observation was that a fraction of
the released MPO is activated during the marathon. The
in vivo regulation of MPO is complex. Indeed the en-
zyme performs its function in a wide variety of envi-
ronments with different pH and levels of NO, H2O2,
O2:, O2, inorganic and organic substrates, and reducing
agents (Klebanoff 2005). Two hypotheses can be pro-
posed to explain the increased levels of active MPO after
the race. First, it could be due to the decrease of the se-
rum levels of lipoprotein, an inhibitor of active MPO, im-
mediately and until one day after a marathon (Goodyear
et al. 1990). Secondly, the peroxidase activity of MPO
could be down regulated by NO (Abu-Soud and Hazen
2000). As a significant reduction in the excretion of
NO metabolites has been demonstrated in marathon
runners, we can speculate that the decrease of NO metab-
olites in serum promote MPO activity (Rodriguez-Plazaet al. 1997). Although we observed for total MPO a differ-
ence between men and women before the marathon race,
it is difficult to assert that this difference is only due to
gender. Indeed, many factors such as smoking, oral con-
traception, anthropomorphic variables, can influence the
concentration of MPO (Hoy et al. 2001). However an im-
portant observation was that a fraction of the released
MPO is active during the marathon whatever the gender.
The in vivo regulation of MPO is complex. The idea was
already explained above.
Conclusions
Our data reveal 1) that long distance running slightly
but significantly decreases type II collagen catabolism.
This finding suggests that long-distance running does
not damage cartilage at short-term; and 2) that the ac-
tive fraction of MPO increases during stressful running
race.
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